Phuong N. Huynh

Array ( [id] => 6664511 [patent_doc_number] => 20030203837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => 'IG/OB fusions and uses thereof' [patent_app_type] => new [patent_app_number] => 10/449317 [patent_app_country] => US [patent_app_date] => 2003-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10269 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20030203837.pdf [firstpage_image] =>[orig_patent_app_number] => 10449317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6829733 [patent_doc_number] => 20030180791 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Anti-proliferation domain of human Bcl-2 and DNA encoding the same' [patent_app_type] => new [patent_app_number] => 10/443982 [patent_app_country] => US [patent_app_date] => 2003-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9948 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20030180791.pdf [firstpage_image] =>[orig_patent_app_number] => 10443982 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7454265 [patent_doc_number] => 20040010376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'Generation and selection of protein library in silico' [patent_app_type] => new [patent_app_number] => 10/443134 [patent_app_country] => US [patent_app_date] => 2003-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 86 [patent_figures_cnt] => 86 [patent_no_of_words] => 64394 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20040010376.pdf [firstpage_image] =>[orig_patent_app_number] => 10443134 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7365054 [patent_doc_number] => 20040005671 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Immunointeractive molecules' [patent_app_type] => new [patent_app_number] => 10/440295 [patent_app_country] => US [patent_app_date] => 2003-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 11532 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20040005671.pdf [firstpage_image] =>[orig_patent_app_number] => 10440295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 520833 [patent_doc_number] => 07186536 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-06 [patent_title] => 'Serine-threonine kinase gene' [patent_app_type] => utility [patent_app_number] => 10/434588 [patent_app_country] => US [patent_app_date] => 2003-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 15 [patent_no_of_words] => 8277 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/186/07186536.pdf [firstpage_image] =>[orig_patent_app_number] => 10434588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 101854 [patent_doc_number] => 07722876 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-25 [patent_title] => 'Toxin-related antibodies with antimicrobial and antiviral activity' [patent_app_type] => utility [patent_app_number] => 10/514781 [patent_app_country] => US [patent_app_date] => 2003-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 21 [patent_no_of_words] => 22148 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/722/07722876.pdf [firstpage_image] =>[orig_patent_app_number] => 10514781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1021238 [patent_doc_number] => 06887672 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-03 [patent_title] => 'Anti-equine Fc epsilon receptor alpha chain antibodies and methods to detect IgE' [patent_app_type] => utility [patent_app_number] => 10/434817 [patent_app_country] => US [patent_app_date] => 2003-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20602 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/887/06887672.pdf [firstpage_image] =>[orig_patent_app_number] => 10434817 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6729644 [patent_doc_number] => 20030185834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Methods and compositions for treating conditions of the eye' [patent_app_type] => new [patent_app_number] => 10/429428 [patent_app_country] => US [patent_app_date] => 2003-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13270 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20030185834.pdf [firstpage_image] =>[orig_patent_app_number] => 10429428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6796409 [patent_doc_number] => 20030175282 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Methods and compositions for treating conditions of the eye' [patent_app_type] => new [patent_app_number] => 10/429496 [patent_app_country] => US [patent_app_date] => 2003-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13275 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175282.pdf [firstpage_image] =>[orig_patent_app_number] => 10429496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7403419 [patent_doc_number] => 20040023880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Methods of inducing formation of functional and organized lymphatic vessels' [patent_app_type] => new [patent_app_number] => 10/427884 [patent_app_country] => US [patent_app_date] => 2003-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5949 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023880.pdf [firstpage_image] =>[orig_patent_app_number] => 10427884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6796398 [patent_doc_number] => 20030175271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'VEGF activity inhibitor' [patent_app_type] => new [patent_app_number] => 10/425668 [patent_app_country] => US [patent_app_date] => 2003-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 27729 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175271.pdf [firstpage_image] =>[orig_patent_app_number] => 10425668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6874076 [patent_doc_number] => 20030194373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-16 [patent_title] => 'Angiogenesis targeting molecules' [patent_app_type] => new [patent_app_number] => 10/420205 [patent_app_country] => US [patent_app_date] => 2003-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16589 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20030194373.pdf [firstpage_image] =>[orig_patent_app_number] => 10420205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7199446 [patent_doc_number] => 20040086507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Antibody inhibiting vplf activity' [patent_app_type] => new [patent_app_number] => 10/399673 [patent_app_country] => US [patent_app_date] => 2003-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 33326 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20040086507.pdf [firstpage_image] =>[orig_patent_app_number] => 10399673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 277737 [patent_doc_number] => 07556809 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-07 [patent_title] => 'Active antiangiogenic therapy' [patent_app_type] => utility [patent_app_number] => 10/511384 [patent_app_country] => US [patent_app_date] => 2003-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13214 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 348 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/556/07556809.pdf [firstpage_image] =>[orig_patent_app_number] => 10511384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5921336 [patent_doc_number] => 20060240004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Methods for treating tweak-related conditions' [patent_app_type] => utility [patent_app_number] => 10/510804 [patent_app_country] => US [patent_app_date] => 2003-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 18942 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10510804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 459086 [patent_doc_number] => 07241446 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-10 [patent_title] => 'Methods for modulating angiogenesis via VEGF' [patent_app_type] => utility [patent_app_number] => 10/506225 [patent_app_country] => US [patent_app_date] => 2003-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 18583 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/241/07241446.pdf [firstpage_image] =>[orig_patent_app_number] => 10506225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7444614 [patent_doc_number] => 20040009538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'Modulation of angiogenesis through targeting of arginyl transferase (ATE1)' [patent_app_type] => new [patent_app_number] => 10/394765 [patent_app_country] => US [patent_app_date] => 2003-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7882 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20040009538.pdf [firstpage_image] =>[orig_patent_app_number] => 10394765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7303230 [patent_doc_number] => 20040115207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Bioconjugates and uses thereof' [patent_app_type] => new [patent_app_number] => 10/181311 [patent_app_country] => US [patent_app_date] => 2003-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19070 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20040115207.pdf [firstpage_image] =>[orig_patent_app_number] => 10181311 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7181833 [patent_doc_number] => 20050124794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Cell surface tropomyosin as a target of angiogenesis inhibition' [patent_app_type] => utility [patent_app_number] => 10/507734 [patent_app_country] => US [patent_app_date] => 2003-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 35903 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20050124794.pdf [firstpage_image] =>[orig_patent_app_number] => 10507734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 295760 [patent_doc_number] => 07541027 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-02 [patent_title] => 'Use of an epitope of vascular endothelial growth factor receptor KDR/Flk-1' [patent_app_type] => utility [patent_app_number] => 10/507164 [patent_app_country] => US [patent_app_date] => 2003-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5889 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/541/07541027.pdf [firstpage_image] =>[orig_patent_app_number] => 10507164 [rel_patent_id] =>[rel_patent_doc_number] =>)